Tobacco Smoke and Alveolar Cell Populations

  • J. Cheretien
  • C. Danel
Part of the Ettore Majorana International Science Series book series (PSLI)

Abstract

The selective study of alveolar cell populations is justified by the physical characteristics of tobacco smoke and by the nature of the disorders observed in the clinic. Before developing this point several preliminary remarks concerning the deep lungs have to be made: What is the exact definition of the deep lung? If one gives an animal, for instance a rat, an aerosol with a radio-active labelled element and records the decrease of radio-activity, one obtains in semi-logarithmic co-ordinates a curve with 3 compartments: a rapid compartment which corresponds to the tracheo-bronchial clearance, an intermediate semi-slow one and a slow compartment (Fig.l). This curve is reduced to two compartments in man (Fig.1). The deep lung corresponds to this slow clearance compartment which involves a retention of particles for a long time. This is, in fact a physiological notion expressing clearance. This notion includes not only the structures for gas-exchange but also the terminal conductive air-ways. In other words there is a bronchio-alveolar unit whose cells cannot be functionally separated in terms of clearance.

Keywords

Permeability Surfactant Dust Silicate Hydrocarbon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    CHRETIEN, J., METIVIER, H., NOLIBE, D., LAFUMA, J., MASSE, R. (1974). “Methodes d’etude des passages particulaires de 1’alveole a 1’interstitium pulmonaire et devenir des particules”. In: Colloques INSERM, vol. 29. Reactions broncho-pulmonaires aux polluants atmospheriques. 1 vol. INSERM. Paris. 133–162.Google Scholar
  2. 2.
    CHRETIEN, J., MARSAC, J., HUCHON, G. (1980). Mechanismes de defense de 1’arbre aerien. Med et Hyg., 38: 1458–1473.Google Scholar
  3. 3.
    CHRETIEN, J. (1980) Penetration et devenir des aero-contaminants inhales par le poumon. In: Allergologie, 1: 308–323. J. Charpin Edit. Flammarion Pub. Paris.Google Scholar
  4. 4.
    CHRETIEN, J., HIRSCH, A., THIFALEMONT, M. (1973). Pathologie respiratoire du tabac. L’experimentation animale dans le monde. Objectifs et methodologie, 1: MASSON Pub. Paris.Google Scholar
  5. 5.
    CHRETIEN, J. (1981). La fumee de tabac. Principaux mecanismes de toxici te. Bull. Europ. Physiopath. resp. 17: 135–144.Google Scholar
  6. 6.
    CHRETIEN, J. (1982). “Inhalation carcinogenesis: an overview”. Recents results in Cancer Research, 82: 1–10.CrossRefGoogle Scholar
  7. 7.
    BIZERTE, G., J. CHRETIEN, C. VOISIN. (1979). Bronchio-alveolar lavage in Man. 1 vol. INSERM Pub. Edit. Paris.Google Scholar
  8. 8.
    Chretien, J., Jaubert, F., Basset, F. (1983). Type II pneumocyte injury in human respiratory diseases. In: The cells of the alveolar unit. Edit. G. Favez, A. Junod, P. Leuen Berger. 1 vol. Hans Huber. Pub. Bern. pp. 56–72.Google Scholar
  9. 9.
    MASSE, R., FRITSCH, P., CHRETIEN, J. (1981). Renouvellement des cellules des bronches et du poumon. Analyse des dossiers recents. Rev. Fr. Mal. Resp. 9: 85–112.Google Scholar
  10. 10.
    Gail, D.B., Lenfant, C. (1983). Cells of the lung: Biology and clinical implications. Am. Rev. Respir. Dis. 9: 366–387.Google Scholar
  11. 11.
    WARR, G.A. (1979). The biology of normal human bronchoalveolar cells. In: Le lavage broncho-alveolaire chez 1’homme. 1 vol. INSERM, Paris, pp. 137–158. G. Bizerte, J. Chretien, C. Voisin, Edit. 544 p.Google Scholar
  12. 12.
    HUNNINGHAKE, G.W., GADEK, J.E., KAWANAMI, O., FERRANS, V.J., CRYSTAL, R.G. (1979). “Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage”. Am. J. Pathol. 97: 149–206.Google Scholar
  13. 13.
    REYNOLDS, H.Y., CHRETIEN, J. (1984). Respiratory tract fluids. Analysis of content and contemporary use in understanding lung diseases. In: Disease-a-Month. Ed. N.J. Cotsonas, Jr., Year Book Medical Publishers, INC. Chicago, 30: 1–103.Google Scholar
  14. 14.
    GREEN, G., SAKAB, G.J., LOW, R.B., DAVIS., G.S. (1976¬1977). Defense mechanisms of respiratory membrane. In: lung disease. State of the art. 245. 1 vol. New York, Editor, Murray, J.J., Publ. American Lung Association 1978.Google Scholar
  15. 15.
    DANIELE, R.P., DAUBER, J.H., ALTOSE, M.D., ROWLANDS, D.T., GORENBERG, D.J. (1977). “Lymphocyte studies in asymptomatic cigarette smokers. A comparison between lung and peripheral blood”. Am. Rev. Respir. Dis., 116: 997–1005.Google Scholar
  16. 16.
    DANIELE, R.P., DAUBER, J.H., ROSSMAN, M.D. (1979). Lymphocyte populations in the bronchoalveolar air spaces: Recent observations in normal and asymptomatic smokers”. Bull. Europ. Physiopath. Resp. 15: 26–27.Google Scholar
  17. 17.
    VENET, A., CLAVEL, F., CHRETIEN, J. (1983). Aspects immunologiques de 1’inf lamination pulmonaire. In: Pneumopathies aigues severes de 1’adulte. J.J. Pocidalo et F. Vachon Edit. Librairie Arnette, Paris, pp. 13–34.Google Scholar
  18. 18.
    CASIO, M.G., HALE, K.A., NIEWOEHNER, D.E. (1982). Morphologic and morphometric effect of prolonged cigarette smoking on the small airways. Am. Rev. Respir. Dis. 122: 265–271.Google Scholar
  19. 19.
    HILLER, F.C., MCCUSKER, K.T., MAZUMDER, M.K., WILSON, D., BONE, R.C. (1982). Deposition of sidestream cigarette smoke in the human respiratory tract. Am. Rev. Respir. Dis. 125: 406–408.Google Scholar
  20. 20.
    HUBERT, G.L., DAUTES, P., ZWILLING, G.R., POCHAN, V.E., HINDS, W.C., NICHOLAS, H.A., MAHASAN, V.K., HAYASHI, M., First. M.W. (1981). A morphologic and physiologic bioassay for quantifying alterations in the lung following experimental chronic inhalations of tobacco smoke. Bull. Eur. Physiopathol. Resp. 17: 270–327.Google Scholar
  21. 21.
    ROTH, C., ARNOUX, A., HUCHON, G., LACRONIQUE, J., MARSAC, J., CHRETIEN, J. (1981). Effet du tabagisme sur les cellules broncho-alveolaires chez 1-homme. Bull. Eur. Physiopathol. Resp. 17: 767–773.Google Scholar
  22. 22.
    RYLANDER, R. (1974). Pulmonary cell response to inhaled cigarette smoke. Arch. Environ. Health. 29: 4–329.Google Scholar
  23. 23.
    CHRETIEN, J., THIELDLEMONT, M., MASSE, R., LEBAS, F.X. (1975). Action de la fumee detabac sur le macrophage alveolaire. Quelques donnees recentes. Nouv. Presse. Med. 4: 2327–2331.Google Scholar
  24. 24.
    BRODY, A.R., CRAIGHEAD, J.E. (1975). Cytoplasmic inclusions in pulmonary macrophages of cigarette smokers. Lab. Invest. 32: 125–132.Google Scholar
  25. 25.
    WARR, G.A., MARTIN, R.R., GENTRY, L.O. (1976). Alteration des macrophages alveolaires pulmonaires chez les jeunes fumeurs de cigarettes. Conf. Intern. de la Tuberculose. Bull. Union. Intern. 1 Vol. 51: 569–577.Google Scholar
  26. 26.
    CARP, H., JANOFF, A. (1978). Possible mechanisms of emphysema in smokers. Am. Rev. Respir. Dis. 118: 617–621.Google Scholar
  27. 27.
    GADEK, J.G., FELLS, G.A., CRYSTAL, R.G. (1979). Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of human. Science, 206: 1315.ADSCrossRefGoogle Scholar
  28. 28.
    HINMAN, L.M., STEVENS, C.A., MATTY, R.A., GEE, B.L. (1980). Elastase and lysozyme activities in human alveolar macrophages. Al. Rev. Respir. Dis. 121: 263–271.Google Scholar
  29. 28.
    HINMAN, L.M., STEVENS, C.A., MATTY, R.A., GEE, B.L. (1980). Elastase and lysozyme activities in human alveolar macrophages. Al. Rev. Respir. Dis. 121: 263–271.Google Scholar
  30. 30.
    LUDWIG, P.W., HOIDAL, J.R. (1982). Alterations in leukocyte oxydation metabolism in cigarette smokers. Am. Rev. Respir. Dis. 126: 977–980.Google Scholar
  31. 31.
    WHITE, R.R., COGGIN, F.R.R. (1982). Effect of cigarette smoke exposure on elastase induced emphysema. Am. Rev. Respir. Dis. 125: (part 2) 214.Google Scholar
  32. 32.
    HUCHON, G.J., RUSSELL, J.A., BARRITAULT, L.G., MURRAY, J.F. (1982). Alveolar capillary membrane permeability in chronic obstructive pulmonary disease and in smokers. Am. Rev. Respir. Dis. 125: 280 (Abstract).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • J. Cheretien
    • 1
  • C. Danel
    • 1
  1. 1.Clinique de Pneumo-Phthisiologie and INSERM U. 214 Hopital Laennec 42ParisFrance

Personalised recommendations